Skip to content
  • Join Us
  • Members Area
ASOI
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research

Publication Category: Weight Loss/Management

Effects of Whole-Body Cryotherapy Combined With Conventional Obesity Management Versus Obesity Management Alone: A Clinical Trial

  • Karppinen JE, Suojanen L, Heinonen S, Kaye S, van der Kolk BW, White JW, Orava J, Lee SHT, Dillon E, Muniandy M, Rissanen A, le Roux CW, Docherty N, Pajukanta P, Virtanen KA, Pietiläinen KH. Effects of Whole-Body Cryotherapy Combined With Conventional Obesity Management Versus Obesity Management Alone: A Clinical Trial Obesity (Silver Spring)

GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England

  • Keating S, Wild C, Scragg J, Dixon S, Treadwell JS, Hinton L, Jebb S. GPs’ perspectives on GLP-1RAs for obesity management: a qualitative study in England Br J Gen Pract

Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management

  • Sherifali D, Racey M, Fitzpatrick-Lewis D, Greenway M, Sockalingam S, Wada J, Teoh SH, Patton I, Macklin D, van Rossum EFC, Busetto L, Horn DB, Patricia Nece JD, Leguede MEGS, Pearce N, Le Roux C, Ard J, Alberga AS, Kaplan L, Sharma AM, Wharton S. Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management Obes Rev

Why do patients with obesity discontinue glucagon-like peptide 1 analogues?

  • Almohaileb FI, le Roux CW, Crotty M. Why do patients with obesity discontinue glucagon-like peptide 1 analogues? Diabetes Obes Metab

Short-term outcomes of endoscopic sleeve gastroplasty

  • Jamal M, Alhashemi M, Althuwaini S, Alsharaf K, Almuhanna M, Alshamali Y, Almousawi A, AlJazzaf I, Alsayegh S, Almuhaini M, Al-Hassani S, Dsouza C; ESG study group. Short-term outcomes of endoscopic sleeve gastroplasty Surg Endosc

Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review

  • Al Lawati A, Alhabsi A, Rahul R, Savino ML, Alwahaibi H, Das S, Al Lawati H. Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review Diseases (Basel, Switzerland)

Subgroup analysis by sex and baseline BMI in people with a BMI ?27kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist

  • le Roux CW, Steen O, Lucas KJ, Startseva E, Unseld A, Hussain SA, Hennige AM. Subgroup analysis by sex and baseline BMI in people with a BMI ?27kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist Diabetes, Obesity and Metabolism

Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study

  • Le Roux CW, Koroleva A, Larsen S, Foot E. Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study Clin Obes

A Core set of patient-reported outcome measures to measure quality of life in obesity treatment research

  • Dijkhorst PJ, de Vries CEE, Terwee CB, Janssen IMC, Liem RSL, van Wagensveld BA, Ottosson J, Halpern B, Flint SW, van Rossum EFC, Saadi A, West-Smith L, O'Kane M, Halford JCG, Coulman KD, Al-Sabah S, Dixon JB, Brown WA, Salas XR, Hoogbergen MM, Abbott S, A Core set of patient-reported outcome measures to measure quality of life in obesity treatment research Obes Rev

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration

  • Galofré JC, Díez JJ, Attanasio R, Nagy EV, Negro R, Papini E, Perros P, Žarković M, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Dobnig H, Fadeyev V, Field BCT, Fliers E, Führe Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration J Endocrinol Invest

Older posts
Newer posts
← Previous Page1 Page2 Page3 … Page24 Next →

Recent Posts

  • 9th ASOI Annual Conference – Registration now open!
  • Press Release for World Obesity Day 4th March 2024
  • ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
  • Things to do in Dublin during ECO
  • ECO 2023 sponsorship update

ASOI

  • info@asoi.info
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Privacy Policy
  • Site Map

©2026 ASOI